↓ Skip to main content

PD-L1 Expression in Triple-Negative Breast Cancer

Overview of attention for article published in Cancer Immunology Research, April 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#14 of 1,588)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
19 news outlets
blogs
1 blog
policy
1 policy source
twitter
14 X users
patent
27 patents

Citations

dimensions_citation
1019 Dimensions

Readers on

mendeley
842 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
PD-L1 Expression in Triple-Negative Breast Cancer
Published in
Cancer Immunology Research, April 2014
DOI 10.1158/2326-6066.cir-13-0127
Pubmed ID
Authors

Elizabeth A. Mittendorf, Anne V. Philips, Funda Meric-Bernstam, Na Qiao, Yun Wu, Susan Harrington, Xiaoping Su, Ying Wang, Ana M. Gonzalez-Angulo, Argun Akcakanat, Akhil Chawla, Michael Curran, Patrick Hwu, Padmanee Sharma, Jennifer K. Litton, Jeffrey J. Molldrem, Gheath Alatrash

X Demographics

X Demographics

The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 842 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 4 <1%
Chile 1 <1%
Austria 1 <1%
Australia 1 <1%
Switzerland 1 <1%
United Kingdom 1 <1%
South Africa 1 <1%
Korea, Republic of 1 <1%
Denmark 1 <1%
Other 0 0%
Unknown 830 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 132 16%
Researcher 124 15%
Student > Bachelor 96 11%
Student > Master 93 11%
Student > Doctoral Student 51 6%
Other 125 15%
Unknown 221 26%
Readers by discipline Count As %
Medicine and Dentistry 181 21%
Biochemistry, Genetics and Molecular Biology 162 19%
Agricultural and Biological Sciences 114 14%
Pharmacology, Toxicology and Pharmaceutical Science 35 4%
Immunology and Microbiology 34 4%
Other 73 9%
Unknown 243 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 165. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 November 2023.
All research outputs
#251,057
of 25,837,817 outputs
Outputs from Cancer Immunology Research
#14
of 1,588 outputs
Outputs of similar age
#2,011
of 240,130 outputs
Outputs of similar age from Cancer Immunology Research
#1
of 27 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,588 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 240,130 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.